Table 3.

MSI status in relation to clinicopathologic features.

		No.	MSS	MSI-H	EMAST	p-value
Stage	I or II	33	15(93.8%)	7(78.5%)	11(73.3%)	0.28
	III	6	1(6.2%)	1(12.5%)	4(26.7%)
Grade	1	20	9(56.3%)	3(37.5%)	8(53.3%)	0.66
	2	11	4(25.0%)	4(50.0%)	3(20.0%)
	3	8	3(18.7%)	1(12.5%)	4(26.7%)
Depth	Endometrium	15	9(56.3%)	0(0.0%)	6(40.0%)	0.06
	<50% of myometrium	18	6(37.5%)	6(75.0%)	6(40.0%)
	>50% of myometrium	6	1(6.2%)	2(25.0%)	3(20.0%)
Total		39	16(41.0%)	8(20.5%)	15(38.5%)

MSS : Microsatellite stable.

MSI : Microsatellite instability – high frequency.

EMAST : Elevated microsatellite alterations at selected tetranucleotide repeat.